Medicenna Therapeutics Statistics

Total Valuation

TSX:MDNA has a market cap or net worth of CAD 72.58 million. The enterprise value is 62.10 million.

Market Cap	72.58M
Enterprise Value	62.10M

Important Dates

The last earnings date was Tuesday, February 10, 2026.

Earnings Date	Feb 10, 2026
Ex-Dividend Date	n/a

Share Statistics

TSX:MDNA has 83.42 million shares outstanding. The number of shares has increased by 9.86% in one year.

Current Share Class	83.42M
Shares Outstanding	83.42M
Shares Change (YoY)	+9.86%
Shares Change (QoQ)	+0.01%
Owned by Insiders (%)	14.35%
Owned by Institutions (%)	n/a
Float	65.95M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	11.68
P/TBV Ratio	11.77
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-4.78
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.68, with a Debt / Equity ratio of 0.02.

Current Ratio	2.68
Quick Ratio	2.50
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -109.77% and return on invested capital (ROIC) is -116.35%.

Return on Equity (ROE)	-109.77%
Return on Assets (ROA)	-61.57%
Return on Invested Capital (ROIC)	-116.35%
Return on Capital Employed (ROCE)	-270.74%
Weighted Average Cost of Capital (WACC)	14.49%
Revenue Per Employee	n/a
Profits Per Employee	-721,556
Employee Count	18
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -16.35% in the last 52 weeks. The beta is 1.87, so TSX:MDNA's price volatility has been higher than the market average.

Beta (5Y)	1.87
52-Week Price Change	-16.35%
50-Day Moving Average	0.91
200-Day Moving Average	1.04
Relative Strength Index (RSI)	47.00
Average Volume (20 Days)	83,858

Short Selling Information

The latest short interest is 222,810, so 0.29% of the outstanding shares have been sold short.

Short Interest	222,810
Short Previous Month	150,128
Short % of Shares Out	0.29%
Short % of Float	0.45%
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-22.31M
Pretax Income	-12.99M
Net Income	-12.99M
EBITDA	-22.31M
EBIT	-22.31M
Earnings Per Share (EPS)	-0.16

Full Income Statement

Balance Sheet

The company has 10.61 million in cash and 135,000 in debt, with a net cash position of 10.48 million or 0.13 per share.

Cash & Cash Equivalents	10.61M
Total Debt	135,000
Net Cash	10.48M
Net Cash Per Share	0.13
Equity (Book Value)	6.21M
Book Value Per Share	0.07
Working Capital	8.09M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-18.44M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

TSX:MDNA does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.86%
Shareholder Yield	-9.86%
Earnings Yield	-17.90%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on March 3, 2017. It was a reverse split with a ratio of 0.0714285.

Last Split Date	Mar 3, 2017
Split Type	Reverse
Split Ratio	0.0714285

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a